Research advances in primary biliary cholangitis / 中华肝脏病杂志
Chinese Journal of Hepatology
; (12): 801-804, 2017.
Article
in Zh
| WPRIM
| ID: wpr-809558
Responsible library:
WPRO
ABSTRACT
Primary biliary cholangitis (PBC) is a chronic cholestatic disease with unknown pathogenesis. Positive anti-mitochondrial antibody has high sensitivity and specificity in the diagnosis of this disease. Ursodeoxycholic acid is mainly used for the treatment of PBC, but 40% of patients have an unsatisfactory biochemical response to this drug. 6-Ethylchenodeoxycholic acid is a new drug approved for the treatment of PBC, and liver transplantation remains the only effective method for the treatment of patients with end-stage PBC.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Hepatology
Year:
2017
Type:
Article